Freeze H H
Glycobiology and Carbohydrate Chemistry Program, The Burnham Institute, La Jolla, California 92037, USA.
Semin Liver Dis. 2001 Nov;21(4):501-15. doi: 10.1055/s-2001-19031.
Congenital disorders of glycosylation (CDG) are caused by defects in protein N-glycosylation. These inherited disorders impact multiple organ systems, including the liver, its glycoprotein products, and the gastrointestinal system. Many patients have hypotonia, psychomotor retardation, developmental delay, and failure to thrive. Limited awareness of CDG and the diverse biological functions of glycosylation contribute to underdiagnosis of these disorders. Pediatric hepatologists and gastroenterologists are likely to encounter CDG patients early on in their workups. This review will discuss the clinical pictures, biochemistry, molecular defects, diagnosis, and, for one type, an effective treatment. The broad and diverse CDG presentations within and between the various types indicate that it should be considered in any case of unexplained developmental delay, hepatopathology, especially hepatic fibrosis and/or steatosis, protein-losing enteropathy, coagulopathy, hypoglycemia, and failure to thrive.
先天性糖基化障碍(CDG)由蛋白质N-糖基化缺陷引起。这些遗传性疾病会影响多个器官系统,包括肝脏、其糖蛋白产物以及胃肠道系统。许多患者存在肌张力减退、精神运动发育迟缓、发育延迟和生长发育不良。对CDG的认识有限以及糖基化的多种生物学功能导致这些疾病的诊断不足。儿科肝病学家和胃肠病学家在其检查过程中很可能较早遇到CDG患者。本综述将讨论临床表现、生物化学、分子缺陷、诊断,以及针对其中一种类型的有效治疗方法。不同类型的CDG在内部和之间表现广泛且多样,这表明在任何不明原因的发育延迟、肝脏病理学(尤其是肝纤维化和/或脂肪变性)、蛋白丢失性肠病、凝血病、低血糖和生长发育不良的病例中都应考虑到该病。